Some biomarkers have been found, such as microsatellite instability, mismatch repair deficient, human epidermal growth factor receptor 2 (HER2), programmed cell death ligand 1 (PD-L1), tumor mutation burden, and Epstein–Barr virus. Here, ERBB2 is linked to neoplasm.